CoChat

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

Open access
Takiar, Vinita, Nishio, Saori, Seo-Mayer, Patricia, King, J. Darwin, Li, Hui, Zhang, Li, Karihaloo, Anil, Hallows, Kenneth R., Somlo, Stefan, Caplan, Michael J. · 2011 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

Renal cyst development and expansion in autosomal dominant polycystic kidney disease (ADPKD) involves both fluid secretion and abnormal proliferation of cyst-lining epithelial cells. The chloride channel of the cystic fibrosis transmembrane conductance regulator (CFTR) participates in secretion of cyst fluid, and the mammalian target of rapamycin (mTOR) pathway may drive proliferation of cyst epithelial cells. CFTR and mTOR are both negatively regulated by AMP-activated protein kinase (AMPK). Metformin, a drug in wide clinical use, is a pharmacological activator of AMPK. We find that metformin stimulates AMPK, resulting in inhibition of both CFTR and the mTOR pathways. Metformin induces significant arrest of cystic growth in both in vitro and ex vivo models of renal cystogenesis. In addition, metformin administration produces a significant decrease in the cystic index in two mouse models of ADPKD. Our results suggest a possible role for AMPK activation in slowing renal cystogenesis as well as the potential for therapeutic application of metformin in the context of ADPKD.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1011498108

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 49 references

Cited by

See all 350

Metadata

Authors
Takiar, V., Nishio, S., Seo-Mayer, P., King, J. D., Li, H., Zhang, L., Karihaloo, A., Hallows, K. R., Somlo, S., & Caplan, M. J.
Affiliations
  • Yale University (US)
  • University of Pittsburgh (US)
Venue
Proceedings of the National Academy of Sciences
Published
2011-01-24
Volume
108
Issue
6
Pages
2462-2467
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2136124373
Cited by
345
References
50
Citations by year
2026: 16 · 2025: 19 · 2024: 21 · 2023: 22 · 2022: 31 · 2021: 28 · 2020: 27 · 2019: 25 · 2018: 32 · 2017: 22 · 2016: 17 · 2015: 17 · 2014: 14 · 2013: 23 · 2012: 16
FWCI
13.57
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Cystic Fibrosis Foundation
  • National Institutes of Health
  • Centers for Disease Control and Prevention (CDMRP PR093488)
  • National Heart, Lung, and Blood Institute (T32HL007563)
  • National Institute of General Medical Sciences (T32GM007205, MSTP TG 5T32GM07205)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 17433, DK-54053, P50DK057328, P01DK017433, F30DK083221, R01DK054053, DK 57328, R01DK075048, R01DK051041, DK-075048, DK51041)
  • Congressionally Directed Medical Research Programs
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Keywords
AMPK, metformin, renal cystogenesis, autosomal dominant polycystic kidney disease, CFTR, mTOR signaling, therapeutic target
MeSH terms
Animals, Cell Line, Disease Models, Animal, Dogs, Epithelial Cells, Humans, Hypoglycemic Agents, Metformin, Mice, Transgenic, Polycystic Kidney, Autosomal Dominant, Cystic Fibrosis Transmembrane Conductance Regulator, Cell Proliferation, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. https://app.cochat.ai/papers/10.1073/pnas.1011498108
The paper
Takiar, V., Nishio, S., Seo-Mayer, P., King, J. D., Li, H., Zhang, L., Karihaloo, A., Hallows, K. R., Somlo, S., & Caplan, M. J. (2011). Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1011498108

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.